Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-01-06

Clinical Trial Update: A Long-term Efficacy, Safety, and Tolerability Study of BOTOX® in Patients With Chronic Migraine [Phase 4]

View source ↗

Summary

Phase 4 study evaluating long-term efficacy, safety, and tolerability of BOTOX in patients with chronic migraine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Botox (OnabotulinumtoxinA)

Snippet

Sponsor: Allergan | Conditions: Migraine Disorders | Phase 4 | Status: COMPLETED | Results posted: 2017-01-06